Compare JPMorgan Ultra Short Income ETF (JPST) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Ultra Short Income ETF vs DENTSPLY SIRONA Inc — how do they compare? JPMorgan Ultra Short Income ETF trades at $50.49, while DENTSPLY SIRONA Inc trades at $13.56 (market cap $2.70B). The key difference: DENTSPLY SIRONA Inc pays a 5.04% dividend while JPMorgan Ultra Short Income ETF pays none, and DENTSPLY SIRONA Inc is trading nearer its 52-week high, JPMorgan Ultra Short Income ETF nearer its low. Which is the better fit depends on your goals.
| JPST | XRAY | |
|---|---|---|
Sector | Leveraged / Inverse | Health |
52-Week High | $50.78 | $16.85 |
52-Week Low | $50.40 | $9.64 |
Market Cap | — | $2.70B |
Enterprise Value | — | $4.84B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JPST (JPMorgan Ultra-Short Income ETF) trades at $50.49, showing minimal daily movement with a slight decline of $0.01 (-0.02%). The ETF maintains a bullish technical signal overall, supported by moving averages, while oscillators remain neutral. Recent institutional activity includes Alpha Zero LLC's $2.30 million investment and Greenwood Gearhart LLC increasing its holdings to $88.04 million, indicating strong institutional confidence. The fund focuses on high-quality, short-term bonds with low duration risk, positioning it as a cash alternative for risk-averse investors.
The outlook for JPST remains stable, benefiting from its ultra-short income strategy amid potential Fed rate stability. Investment opportunities include capital preservation and steady income via dividends, with recent payouts of $0.17-$0.18. Risks involve interest rate sensitivity and inflationary pressures, though the ETF's low duration mitigates volatility. Institutional accumulation and positive media coverage support a cautious bullish stance for income-focused portfolios.
Dentsply Sirona (XRAY) trades at $13.65, down 2.91% on the day, with a mixed technical picture showing a bullish moving average signal but overbought RSI levels. Fundamentally, the company reported a net loss of $598 million for 2025, with negative profit margins and an elevated EV/EBITDA of 91.48, though revenue remains stable near $3.7 billion. Recent news includes the appointment of a new CFO and expanded U.S. distribution partnerships, while the upcoming Q2 2026 earnings call on August 6 is a key near-term catalyst.
The outlook remains challenging due to persistent losses and margin pressure, offset by strategic growth initiatives. Investment opportunities lie in the company's market leadership and digital dentistry expansion, but risks include high debt levels, competitive pressures, and the need for a successful turnaround. Analyst consensus is Hold with a price target of $13.33, indicating limited near-term upside from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Ultra Short Income ETF
JPST is an actively managed ETF that invests in short-term, investment-grade fixed income securities. It aims to provide current income and capital preservation while maintaining high liquidity.
Read more on JPST →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
